The Effect of Triflusal on Peripheral Microcirculation Dysfunction
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
To explore the efficacy of triflusal in patients with symptomatic peripheral microcirculation
dysfunction. Triflusal is a salicylate compound approved in several countries as
antithrombotic agent and it additionally has vasodilatory effect. The hypothesis is to
explore if there is a improvement of peripheral microcirculation by triflusal.